Jincheng Pharmaceutical (300233.SZ) subsidiary's tobacco monopoly production enterprise license renewal and change, nicotine approved production capacity for electronic cigarettes increased to no more than 200 tons per year.

Zhitan Finance and Economics APP news, Jincheng Pharmaceutical (300233.SZ) announced that its wholly-owned subsidiary Shandong Jincheng Pharmaceutical Chemical Co., Ltd. (hereinafter referred to as "Jincheng Medical Chemistry") received the "Tobacco Monopoly Production Enterprise License" (electronic cigarette nicotine production enterprise) issued by the National Tobacco Monopoly Bureau on July 18, 2025. The issued "Tobacco Monopoly Production Enterprise License" this time will be extended until June 30, 2028, and the relevant content of the original license has been changed.